Kate Therapeutics Debuts With $51 Million Series A To Develop Next-Generation Genetic Medicines To Treat Muscle And Heart Diseases
Amount Raised
$51 Million
Round Type
Series A
San DiegoBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
Kate Therapeutics Inc. ("KateTx"), a next-generation gene therapy company, today emerged from stealth mode with a $51 million Series A financing co-led by founding investor Westlake Village BioPartners and Versant Ventures, with participation from Osage University Partners and UF Innovate | Ventures. In addition, the company has granted Astellas Pharma Inc. an exclusive, worldwide license to develop, manufacture and commercialize KT430 to treat X-linked myotubular myopathy (XLMTM), the details of which are described in a separate press release issued today.
Quick answer
Kate Therapeutics raised $51 Million in a Series A round, dated June 8, 2023. Investors: UF Innovate | Ventures, Osage University Partners, Versant Ventures and Westlake Village Bio Partners. Kate Therapeutics is based in San Diego, California, United States.
- How much did Kate Therapeutics raise?
- Kate Therapeutics raised $51 Million in a Series A round on June 8, 2023.
- Who invested in Kate Therapeutics?
- UF Innovate | Ventures, Osage University Partners, Versant Ventures and Westlake Village Bio Partners are named as investors in this round.
- What does Kate Therapeutics do?
- Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.
- Where is Kate Therapeutics based and how big is it?
- Kate Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Kate Therapeutics?
- Fundz holds 1 contact at Kate Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Kate Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- KayoThera, Inc. raised an undisclosed amount (Series A) on July 19, 2023.
- SURGE Therapeutics raised $32M (Series B) on July 19, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Tenpoint Therapeutics raised $70M (Series A) on July 12, 2023.
- Smartlens raised $6.1M (Series A) on July 11, 2023.
- TolerogenixX raised $13M (Series A) on July 6, 2023.
Who to call at Kate Therapeutics, and when
A new round usually means Kate Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kate Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kate Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kate Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kate Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKate Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.